Neonatal sepsis caused by a CTX-M-32-producing Escherichia coli isolate.
We describe what we believe to be the first case of neonatal sepsis caused by CTX-M-producing Escherichia coli, in a low-weight preterm infant, born to a colonized mother who had received antibiotic treatment antepartum. Increased dissemination of extended-spectrum beta-lactamase-producing E. coli in the community should be borne in mind for empirical therapy of sepsis in high-risk newborns.
López-Cerero
Lorena
L
Microbiology Department, University Hospital Virgen Macarena, Seville, Spain.
De Cueto
Marina
M
Microbiology Department, University Hospital Virgen Macarena, Seville, Spain.
Saenz
Carlos
C
Neonatology Unit, University Hospital Virgen Macarena, Seville, Spain.
Navarro
Dolores
D
Infectious Diseases Unit, University Hospital Virgen Macarena, Seville, Spain.
Velasco
Carmen
C
Microbiology Department, Faculty of Medicine, University of Seville, Spain.
Rodríguez-Baño
Jesús
J
Infectious Diseases Unit, University Hospital Virgen Macarena, Seville, Spain.
Pascual
Alvaro
A
Microbiology Department, Faculty of Medicine, University of Seville, Spain.|Microbiology Department, University Hospital Virgen Macarena, Seville, Spain.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004926:Escherichia coli / Q000201:enzymology*; D004927:Escherichia coli Infections / Q000382:microbiology* / Q000635:transmission; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000382:microbiology*; D018445:Infectious Disease Transmission, Vertical; D008297:Male; D000077731:Meropenem; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology; D018805:Sepsis / Q000382:microbiology*; D013845:Thienamycins / Q000627:therapeutic use; D001618:beta-Lactamases / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D013845:Thienamycins; D001618:beta-Lactamases; C487656:beta-lactamase CTX-M-32, E coli; D000077731:Meropenem